CHM 0.00% 1.4¢ chimeric therapeutics limited

Potential suitor for CHM is BioNTech. They have USD21bn in the...

  1. 78 Posts.
    lightbulb Created with Sketch. 32
    Potential suitor for CHM is BioNTech. They have USD21bn in the bank and have stated they want to build an oncology pipeline. Augurs well for leading cell therapy companies such as CHM l!
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.4¢
Change
0.000(0.00%)
Mkt cap ! $12.67M
Open High Low Value Volume
1.4¢ 1.5¢ 1.4¢ $12.73K 890.2K

Buyers (Bids)

No. Vol. Price($)
10 2014769 1.3¢
 

Sellers (Offers)

Price($) Vol. No.
1.5¢ 449172 4
View Market Depth
Last trade - 15.56pm 26/09/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.